OBA SHINSUKE,YASUJI TAKEHIKO,HAKOMORI TADASHI,SAKO KAZUHIRO
申请号：
EP09817722
公开号：
EP2343076A4
申请日:
2009.09.28
申请国别(地区):
EP
年份:
2012
代理人:
摘要：
A pharmaceutical composition for oral administration, comprising 3-hydroxy-N1-(4-methoxybenzoyl)-N2-[4-(4-methyl-1,4-diazepan-1-yl)benzoyl]-1,2-phenylenediamine or a pharmaceutically acceptable salt thereof, and hydroxypropyl cellulose having a viscosity of approximately 6 mPa•S (inclusive) to approximately 150 mPa•S (exclusive) in a 2% aqueous solution at 20°C, or a viscosity of 75 mPa•S (inclusive) to 400 mPa•S (inclusive) in a 5% aqueous solution at 25°C, and a process of manufacturing the pharmaceutical composition for oral administration are disclosed.
